Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

27277studies shown

Showing 3,601-3,612 of 27,277

RecruitingNCT05752448

POSTCARE-O survivorship support after ovarian cancer treatment

About this title

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Read the official source — NCT05752448

Official study title

POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer

In Houston

DepressionBehavioural studyAges 18+

Countries: United States
Sponsor: Baylor College of Medicine

View study

RecruitingNCT06900400

Sustained internal attention in people with ADHD

About this title

Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder

Read the official source — NCT06900400

Official study title

Evaluation of Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder: Validation of a Computerized Neuropsychological Test."

Multiple locations, including Brindisi

ADHDStudy assessmentsAges 6–13

Countries: Italy
Sponsor: IRCCS Eugenio Medea

View study

RecruitingNCT06732596

Smartphone conversational support during buprenorphine treatment

About this title

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

Read the official source — NCT06732596

Official study title

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

In Boston

AddictionInterventional studyAges 18+

Countries: United States
Sponsor: Boston Medical Center

View study

RecruitingNCT06326684

Suvorexant or placebo in a study of alcohol-related motivation and behavior

About this title

Suvorexant and Alcohol

Read the official source — NCT06326684

Official study title

Influence of Orexin Antagonism on Motivation for Alcohol

In Lexington

AddictionMedication studyAges 21–55

Countries: United States
Sponsor: William Stoops

View study

RecruitingNCT06484075

Suvorexant or placebo and brain dopamine in people with alcohol use

About this title

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Read the official source — NCT06484075

Official study title

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

In Bethesda

AddictionMedication studyAges 18–75

Countries: United States
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

View study

RecruitingNCT06679062

Suvorexant for sleep problems with alcohol use and post-traumatic stress

About this title

Suvorexant for Treatment of AUD and PTSD

Read the official source — NCT06679062

What is this study about?

This study evaluates the effectiveness of Suvorexant for people with PTSD.

In Houston

PTSD, AddictionMedication studyAges 21–65

Countries: United States
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance

View study

RecruitingNCT03642028

Suvorexant and sleep problems related to PTSD

About this title

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

Read the official source — NCT03642028

Official study title

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress

Multiple locations, including Long Beach

PTSDMedication studyAges 18–75

Countries: United States
Sponsor: VA Office of Research and Development (Government agency)

View study

RecruitingNCT05472818

Brain imaging before and after cannabis abstinence in people with cannabis use disorder

About this title

SV2A Density Cannabis Use Disorder

Read the official source — NCT05472818

Official study title

SV2A Density Cannabis Use Disorder

In New Haven

AddictionMedication studyAges 18–75

Countries: United States
Sponsor: Yale University

View study

RecruitingACTRN12625000835448

Sweat, Sleep, and Sobriety: Physical Activity and Sleep in Alcohol and Other Drugs Recovery

Official study title

Impact of Physical Activity on Sleep in Adults Recovering from Substance Use Disorders: An Observational Study

In Australia

AddictionObservational studyAges 18+

Countries: Australia
Sponsor: Curtin University

View study

RecruitingNCT05996172

Combining support options to quickly stabilize suicide risk in young people

About this title

Swift Outpatient Alternatives for Rapid Stabilization

Read the official source — NCT05996172

Official study title

Swift Outpatient Alternatives for Rapid Stabilization

In Seattle

SuicidalityBehavioural studyAges 13–21

Countries: United States
Sponsor: University of Washington

View study

RecruitingNCT02639702

Switching from twice-daily to once-daily clozapine in schizophrenia

About this title

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Read the official source — NCT02639702

Official study title

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia: A Pilot, Double-Blind, Randomized Controlled Trial

In Toronto

SchizophreniaMedication studyAges 18+

Countries: Canada
Sponsor: Centre for Addiction and Mental Health (Hospital / academic medical center)

View study

RecruitingACTRN12605000516684

Switching to aripiprazole from other second-generation antipsychotics.

Official study title

A randomised phase IV study to compare two rates of dosage tapering, when switching patients to aripiprazole from other atypical antipsychotics for the treatment of schizophrenia and schizoaffective disorder

Location not clearly listed

SchizophreniaInterventional study

Countries
Sponsor: Bristol Meyers Squibb Pharmaceuticals

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.